Mean follow-up after vaccination was 16 months per participant in the Pfizer phase 3 RSV vaccine trial (median 17 months) and 19 months in the GSK phase 3 RSV vaccine trial (median 23 months).
Sources
- Protein subunit RSV vaccines (GSK Arexvy and Pfizer ... - CDC (cdc.gov)
- https://labeling.pfizer.com/ShowLabeling.aspx?id=19589 (labeling.pfizer.com)
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175669/ (ncbi.nlm.nih.gov)
- https://www.gsk.com/en-gb/media/press-releases/gsk-presents-positive-data-for-arexvy-its-rsv-vaccine-indicating-protection-over-three-rsv-seasons/ (gsk.com)
- https://www.patientcareonline.com/view/gsk-3-year-efficacy-data-for-arexvy-in-older-adults-published-in-lancet-respiratory-medicine (patientcareonline.com)
More in Science
- Temperature data for the sea just south of Greenland dates back to 1870.
- The researchers' experiment involved balls bouncing as if on a racquetball court, with participants watching the animation until the balls vanished and then predicting when they would have reached the ground.
- Peter Whoriskey of The Washington Post reported that the dietary-cholesterol finding would be included in the Dietary Guidelines Advisory Committee's final report, due within weeks of February 2015.
- The U.S. Food and Drug Administration lists monosodium glutamate (MSG) as safe to eat in typical amounts.
- Massive volcanism 252 million years ago caused rapid environmental change that eliminated most animal species on Earth.
- Humans produce about 2 liters of saliva per day.